Aspen Pharmacare's market cap is currently ―. The company's EPS TTM is $0.593; its P/E ratio is 20.73; and it has a dividend yield of 1.04%. Aspen Pharmacare is scheduled to report earnings on September 3, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	Rs 8.04B	Rs 6.18B	Rs 7.88B	Rs 8.55B	Rs 9.79B
Total Assets	Rs 120.58B	Rs 111.38B	Rs 117.34B	Rs 109.68B	Rs 124.21B
Total Debt	Rs 26.80B	Rs 22.25B	Rs 27.19B	Rs 24.87B	Rs 37.48B
Net Debt	Rs 18.75B	Rs 16.06B	Rs 19.31B	Rs 16.33B	Rs 27.68B
Total Liabilities	-	Rs 40.43B	Rs 45.38B	Rs 44.06B	Rs 57.85B
Stockholders Equity	Rs 75.21B	Rs 70.94B	Rs 71.96B	Rs 65.63B	Rs 66.35B
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in ZAR

Aspen Pharmacare Earnings and Revenue History

Income Statement >

Aspen Pharmacare Debt to Assets

Balance Sheet >

Aspen Pharmacare Cash Flow

Cash Flow >

Aspen Pharmacare Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing